Glucagon-Like Peptide-1 and Dual Incretin Agonists in Type 2 Diabetes with Peripheral Artery Disease: A Systematic Review and Meta-Analysis of Vascular, Cardiovascular, Metabolic, and Mortality Outcomes : Incretin Therapy in T2DM and PAD.

Saved in:
Bibliographic Details
Title: Glucagon-Like Peptide-1 and Dual Incretin Agonists in Type 2 Diabetes with Peripheral Artery Disease: A Systematic Review and Meta-Analysis of Vascular, Cardiovascular, Metabolic, and Mortality Outcomes : Incretin Therapy in T2DM and PAD.
Authors: Araújo de Lucena L; Federal University of Rio Grande do Norte, Natal, RN, Brazil., Cavalcante DVS; University of North Texas Health Science Center, Fort Worth, TX, USA., Montenegro MV; University of Pernambuco, Recife, PE, Brazil., Hespanhol LC; Federal University of Campina Grande, Cajazeiras, PB, Brazil., de Oliveira WS; Federal University of Rio Grande do Norte, Natal, RN, Brazil., Muniz JQ; Schmieder Klinik Heidelberg, Heidelberg, Germany., Prathivadhi-Bhayankaram S; University of Illinois, Chicago, IL, USA., Kaplinsky E; Hospital Municipal de Badalona, Barcelona, Spain., Barbagelata A; Universidad Catolica Argentina, Buenos Aires, Argentina.; Duke University, Durham, NC, USA., Giorgi J; Sírio-Libanês Hospital, São Paulo, SP, Brazil. julianagiorgi@hotmail.com.; Albert Einstein Hospital, São Paulo, São Paulo, Brazil. julianagiorgi@hotmail.com.
Source: Current diabetes reports [Curr Diab Rep] 2026 Mar 10; Vol. 26 (1). Date of Electronic Publication: 2026 Mar 10.
Publication Type: Journal Article; Systematic Review; Meta-Analysis; Review
Journal Info: Publisher: Current Science Country of Publication: United States NLM ID: 101093791 Publication Model: Electronic Cited Medium: Internet ISSN: 1539-0829 (Electronic) Linking ISSN: 15344827 NLM ISO Abbreviation: Curr Diab Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1539-0829
DOI:10.1007/s11892-026-01619-4